81 related articles for article (PubMed ID: 9367268)
1. Local muscimol disinhibits mesolimbic dopaminergic activity as examined by brain microdialysis and Fos immunohistochemistry.
Yoshida M; Yokoo H; Nakahara K; Tomita M; Hamada N; Ishikawa M; Hatakeyama J; Tanaka M; Nagatsu I
Brain Res; 1997 Sep; 767(2):356-60. PubMed ID: 9367268
[TBL] [Abstract][Full Text] [Related]
2. Role of GABAA receptors in the endomorphin-1-, but not endomorphin-2-, induced dopamine efflux in the nucleus accumbens of freely moving rats.
Aono Y; Saigusa T; Mizoguchi N; Iwakami T; Takada K; Gionhaku N; Oi Y; Ueda K; Koshikawa N; Cools AR
Eur J Pharmacol; 2008 Feb; 580(1-2):87-94. PubMed ID: 18021767
[TBL] [Abstract][Full Text] [Related]
3. Opposite changes in the mesolimbic dopamine metabolism in the nerve terminal and cell body sites induced by locally infused baclofen in the rat.
Yoshida M; Yokoo H; Tanaka T; Emoto H; Tanaka M
Brain Res; 1994 Feb; 636(1):111-4. PubMed ID: 8156399
[TBL] [Abstract][Full Text] [Related]
4. Muscimol-induced increase in dopamine release and metabolism is not observed in kainic acid-lesioned striatum of conscious rats: an in vivo microdialysis study.
Yoshida M; Mizoguchi K; Yokoo H; Tanaka T; Ishii H; Emoto H; Koga C; Tanaka M
Neurosci Lett; 1993 Nov; 162(1-2):5-8. PubMed ID: 8121635
[TBL] [Abstract][Full Text] [Related]
5. Changes in dopamine transporter and c-Fos expression in the nucleus accumbens of alcohol-tolerant rats.
Yoshimoto K; Ueda S; Nishi M; Yang Y; Matsushita H; Takeuchi Y; Kato B; Kawai Y; Noritake K; Kaneda S; Sorimachi Y; Yasuhara M
Alcohol Clin Exp Res; 2000 Mar; 24(3):361-5. PubMed ID: 10776677
[TBL] [Abstract][Full Text] [Related]
6. Nicotine injections into the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rat.
Panagis G; Nisell M; Nomikos GG; Chergui K; Svensson TH
Brain Res; 1996 Aug; 730(1-2):133-42. PubMed ID: 8883897
[TBL] [Abstract][Full Text] [Related]
7. Region-related Fos expression in hypothalamic dopaminergic neurons of rats by intraperitoneal administration of an endogenous satiety substance, 2-buten-4-olide.
Hisano S; Zhang R; Uemura N; Fukui Y; Miki T
Brain Res; 1995 Apr; 676(2):409-12. PubMed ID: 7614014
[TBL] [Abstract][Full Text] [Related]
8. Intranasal dopamine application increases dopaminergic activity in the neostriatum and nucleus accumbens and enhances motor activity in the open field.
de Souza Silva MA; Topic B; Huston JP; Mattern C
Synapse; 2008 Mar; 62(3):176-84. PubMed ID: 18081176
[TBL] [Abstract][Full Text] [Related]
9. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH
J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500
[TBL] [Abstract][Full Text] [Related]
10. Effects of CCK8 and of the CCKB-selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: a microdialysis study in freely moving rats.
Ladurelle N; Keller G; Roques BP; Daugé V
Brain Res; 1993 Nov; 628(1-2):254-62. PubMed ID: 8313154
[TBL] [Abstract][Full Text] [Related]
11. Facilitatory modulation of mesolimbic dopamine neuronal activity by a mu-opioid agonist and nicotine as examined with in vivo microdialysis.
Yoshida M; Yokoo H; Tanaka T; Mizoguchi K; Emoto H; Ishii H; Tanaka M
Brain Res; 1993 Oct; 624(1-2):277-80. PubMed ID: 8252400
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats.
Kääriäinen TM; Lehtonen M; Forsberg MM; Savolainen J; Käenmäki M; Männistö PT
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):50-8. PubMed ID: 17971064
[TBL] [Abstract][Full Text] [Related]
13. Lead intoxication during intrauterine life and lactation but not during adulthood reduces nucleus accumbens dopamine release as studied by brain microdialysis.
Devoto P; Flore G; Ibba A; Fratta W; Pani L
Toxicol Lett; 2001 May; 121(3):199-206. PubMed ID: 11369474
[TBL] [Abstract][Full Text] [Related]
14. Involvement of 5-HT1B receptors within the ventral tegmental area in regulation of mesolimbic dopaminergic neuronal activity via GABA mechanisms: a study with dual-probe microdialysis.
Yan QS; Zheng SZ; Yan SE
Brain Res; 2004 Sep; 1021(1):82-91. PubMed ID: 15328035
[TBL] [Abstract][Full Text] [Related]
15. In vivo neurochemical evidence that newly synthesised GABA activates GABA(B), but not GABA(A), receptors on dopaminergic nerve endings in the nucleus accumbens of freely moving rats.
Saigusa T; Aono Y; Sekino R; Uchida T; Takada K; Oi Y; Koshikawa N; Cools AR
Neuropharmacology; 2012 Feb; 62(2):907-13. PubMed ID: 21964521
[TBL] [Abstract][Full Text] [Related]
16. Oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats.
Melis MR; Melis T; Cocco C; Succu S; Sanna F; Pillolla G; Boi A; Ferri GL; Argiolas A
Eur J Neurosci; 2007 Aug; 26(4):1026-35. PubMed ID: 17672853
[TBL] [Abstract][Full Text] [Related]
17. Intraaccumbal mecamylamine infusion does not affect dopamine output in the nucleus accumbens of chronically nicotine-treated rats.
Hildebrand BE; Svensson TH
J Neural Transm (Vienna); 2000; 107(8-9):861-72. PubMed ID: 11041268
[TBL] [Abstract][Full Text] [Related]
18. Systemic administration of CCK-8S, but not CCK-4, enhances dopamine turnover in the posterior nucleus accumbens: a microdialysis study in freely moving rats.
Kariya K; Tanaka J; Nomura M
Brain Res; 1994 Sep; 657(1-2):1-6. PubMed ID: 7820607
[TBL] [Abstract][Full Text] [Related]
19. Repeated administration of the selective kappa-opioid receptor agonist U-69593 increases stimulated dopamine extracellular levels in the rat nucleus accumbens.
Fuentealba JA; Gysling K; Magendzo K; Andrés ME
J Neurosci Res; 2006 Aug; 84(2):450-9. PubMed ID: 16676328
[TBL] [Abstract][Full Text] [Related]
20. Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
Hildebrand BE; Nomikos GG; Hertel P; Schilström B; Svensson TH
Brain Res; 1998 Jan; 779(1-2):214-25. PubMed ID: 9473676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
